NEW YORK (GenomeWeb) – The National Cancer Institute will provide up to $4.5 million next year to fund research teams performing omics studies to characterize tumor lesions discovered through screening, with the aim of better predicting which lesions are progressive and require interventions and which are indolent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.